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WE DANCE ROUND IN A RING AND SUPPOSE, 
BUT THE SECRET SITS IN THE MIDDLE AND KNOWS. 
 ROBERT FROST 
HIV-ASSOCIATED KAPOSI'S SARCOMA SPINDLE CELLS: 
SMOOTH MUSCLE ORIGIN AND IMMUNOLOGICAL LINK 
  
• Here I will focus on (i) a possible smooth muscle 
cell (SMC) origin of HIV-associated Kaposi's sarcoma 
(KS) spindle cells, and (ii) their growth control by acti- 
vated immune cell-derived cytokines (1-3). The following 
is considered: 
(i) if KS spindle cells, or a subpopulation of them, derived 
from SMC (1), they should then also reveal other features 
of SMC that are not explored in KS spindle cells. One of 
these "other features" is the readiness of vascular SMC to 
shape-change, from spindle to stellate, in response to beta- 
adrenergic stimulation (4,5) and to an actin-destroying 
agent, cytochalsin B (4). Further, this process is (a) 
cytoskeleton-dependent, and (b) pharmacologically pre- 
ventable by antitubulins, such as colchicine (4) and by pro- 
tein kinase C activators (5). Meanwhile, this SMC shape- 
change was first described in 1866 by Langhans (6), but 
neglected by Rudolph Virchow, in human atherosclerosis. 
(ii) because tumor necrosis factor (TNF)'s growth stimu- 
lation index over KS spindle cells is one of the highest 
between other growth factors tested (1, their Table 5), the 
following recent data should be kept in mind (a) TNF pro- 
duction is regulated by beta-adrenergic agonists (7), (b) 
antitubulins downregulate TNF receptors (8), (c) 
colchicine prevents TNF-induced toxicity (9), and (d) the 
shared actions of endotoxin and the microtubule-stabiliz- 
ing agent taxol on TNF receptors and TNF release (10). 
Hence a possible pharmacological control over hyperpla- 
sia in HIV-associated KS spindle cells, using anti-TNF 
agents proposed for research in AIDS therapy (11-13), 
seems to be a promiseful approach together with some 
folklore's "counter irritants" with antioxidant activity, e.g. 
turmeric (see 14) and some drugs known to inhibit SMC's 
secretion, e.g. colchicine (15), and possibly brefeldin A 
(see 16). 
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